Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Whaley

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Biology of Reproduction|July 2, 2020
Engineering monoclonal antibody-based contraception and multipurpose prevention technologies†Deborah J Anderson, Joseph A Politch, Richard A Cone, et al.
Clinical and Vaccine Immunology : CVI|July 29, 2016
Humanized Monoclonal Antibody That Passively Protects Mice against Systemic and Intranasal Ricin Toxin ChallengeGreta Van Slyke, Erin K Sully, Natasha Bohorova, et al.
Journal of Immunological Methods|April 14, 2015
Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharideKara J Levinson, Samantha R Giffen, Michael H Pauly, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2011
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectantLarry Zeitlin, James Pettitt, Corinne Scully, et al.
Plos One|March 30, 2023
LALAPG variant of the Human Contraception Antibody (HCA) reduces Fc-mediated effector functions while maintaining sperm agglutination activityEmilie Mausser, Ellena Nador, Joseph A Politch, et al.
Emerging Microbes & Infections|May 7, 2024
ZMapp reduces diffusion of Ebola viral particles in fresh human cervicovaginal mucusAlison Schaefer, Bing Yang, Holly A Schroeder, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2014
Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacyAndrew Hiatt, Natasha Bohorova, Ognian Bohorov, et al.
Methods in Enzymology|November 7, 2021
Manufacturing plant-made monoclonal antibodies for research or therapeutic applicationsKelsi Swope, Josh Morton, Gregory P Pogue, et al.
Mucosal Immunology|July 11, 2018
Herpes simplex virus-binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial compositionHolly A Schroeder, Kenetta L Nunn, Alison Schaefer, et al.
The Journal of Clinical Investigation|January 24, 2002
Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agentKristen V Khanna, Kevin J Whaley, Larry Zeitlin, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Biology of Reproduction|July 2, 2020
Engineering monoclonal antibody-based contraception and multipurpose prevention technologies†Deborah J Anderson, Joseph A Politch, Richard A Cone, et al.
Clinical and Vaccine Immunology : CVI|July 29, 2016
Humanized Monoclonal Antibody That Passively Protects Mice against Systemic and Intranasal Ricin Toxin ChallengeGreta Van Slyke, Erin K Sully, Natasha Bohorova, et al.
Journal of Immunological Methods|April 14, 2015
Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharideKara J Levinson, Samantha R Giffen, Michael H Pauly, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2011
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectantLarry Zeitlin, James Pettitt, Corinne Scully, et al.
Plos One|March 30, 2023
LALAPG variant of the Human Contraception Antibody (HCA) reduces Fc-mediated effector functions while maintaining sperm agglutination activityEmilie Mausser, Ellena Nador, Joseph A Politch, et al.
Emerging Microbes & Infections|May 7, 2024
ZMapp reduces diffusion of Ebola viral particles in fresh human cervicovaginal mucusAlison Schaefer, Bing Yang, Holly A Schroeder, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2014
Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacyAndrew Hiatt, Natasha Bohorova, Ognian Bohorov, et al.
Methods in Enzymology|November 7, 2021
Manufacturing plant-made monoclonal antibodies for research or therapeutic applicationsKelsi Swope, Josh Morton, Gregory P Pogue, et al.
Mucosal Immunology|July 11, 2018
Herpes simplex virus-binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial compositionHolly A Schroeder, Kenetta L Nunn, Alison Schaefer, et al.
The Journal of Clinical Investigation|January 24, 2002
Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agentKristen V Khanna, Kevin J Whaley, Larry Zeitlin, et al.
Pageof 6